GUGGENHEIM CAPITAL LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 83 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$447,000
-92.9%
49,849
-87.6%
0.00%
-93.8%
Q2 2015$6,338,000
+210.5%
401,391
+88.6%
0.02%
+220.0%
Q3 2014$2,041,000
+54.4%
212,779
+85.9%
0.01%
+66.7%
Q2 2014$1,322,000
-47.6%
114,458
-54.6%
0.00%
-57.1%
Q1 2014$2,521,000
-4.6%
252,105
+24.2%
0.01%
-12.5%
Q4 2013$2,643,000202,9850.01%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders